ClinicalTrials.Veeva

Menu

Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Adjuvant Chemotherapy
Distal Cholangiocarcinoma

Treatments

Drug: Adjuvant chemotherapy

Study type

Observational

Funder types

Other

Identifiers

NCT06671431
2408-168-1565

Details and patient eligibility

About

Recent studies addressing the role of adjuvant chemotherapy in cholangiocarcinoma (CCA) have been published; however, there are challenges in generalizing the findings due to different prognostic characteristics depending on tumor location and resectability. Therefore, the aim of this study was to investigate the role of AC in distal cholangiocarcinoma, a common tumor subtype of CCA.

Enrollment

578 patients

Sex

All

Ages

19 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with distal cholangiocarcinoma who underwent surgery

Exclusion criteria

  • Who underwent neoadjuvant treatment
  • Who underwent R2 resection
  • Non-adenocarcinoma patients in final pathology report
  • Insufficient data
  • Death within 90days of surgery

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems